Want to see CRVL full AI Analyst Report?
CRVL Stock Chart & Stats
$59.86
$0.85(1.44%)
At close: 4:00 PM EDT
$59.86
$0.85(1.44%)
Day’s Range― - ―
52-Week Range$44.83 - $93.71
Previous Close$59.86
Volume129.08K
Average Volume (3M)163.23K
Market Cap
$3.09B
Enterprise Value$2.96K
Total Cash (Recent Filing)$255.88M
Total Debt (Recent Filing)$28.39M
Price to Earnings (P/E)27.9
Beta0.60
Next Earnings
Nov 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.25
Shares Outstanding50,516,570
10 Day Avg. Volume168,294
30 Day Avg. Volume163,227
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)7.11
Price to Sales (P/S)2.92
P/FCF Ratio25.41
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA conservatively positioned balance sheet with minimal debt and sizable cash provides durable financial flexibility. It supports funding of technology investments, M&A optionality, continued share repurchases and cushions against cyclical insurance volatility without constraining operations.
Profitability & Cash GenerationHigh margins, elevated ROE and substantial free cash flow indicate efficient capital use and sustainable profitability. This cash generation underpins reinvestment in product development, supports working capital needs and enables long-term returns to shareholders even if growth moderates.
Commercial Momentum & Scalable TechAccelerating bookings and RFP activity combined with CERIS, prepaid solutions and AI/automation investments strengthen durable demand and operational scalability. Multiyear payer implementations shorten realization cycles and can convert pipeline wins into recurring, higher‑margin revenue over time.
Bears Say
Revenue Growth DecelerationA clear slowdown to low single‑digit TTM top‑line growth makes future upside more dependent on margin expansion and efficiency. If market pricing or claim volumes weaken, limited revenue momentum could constrain sustainable earnings growth over the medium term.
Timing-related CERIS ContributionsPortions of recent CERIS gains were one‑time or timing‑driven, meaning elevated margins or EPS benefits may not fully recur. Reliance on such episodic items to meet targets risks earnings volatility unless underlying recurring adoption and realized savings scale consistently.
Industry Pressure & Operating CostsStructural industry headwinds—higher medical severity, provider access constraints—and rising personnel and cybersecurity costs raise operating risk. These factors can erode margins and require sustained investment in governance and automation to preserve service levels and cost advantage.
CorVel News
CRVL FAQ
What was CorVel Corporation’s price range in the past 12 months?
CorVel Corporation lowest stock price was $44.83 and its highest was $93.70 in the past 12 months.
What is CorVel Corporation’s market cap?
CorVel Corporation’s market cap is $3.09B.
When is CorVel Corporation’s upcoming earnings report date?
CorVel Corporation’s upcoming earnings report date is Nov 03, 2026 which is in 81 days.
How were CorVel Corporation’s earnings last quarter?
CorVel Corporation released its earnings results on Aug 05, 2026. The company reported $0.633 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is CorVel Corporation overvalued?
According to Wall Street analysts CorVel Corporation’s price is currently Overvalued.
Does CorVel Corporation pay dividends?
CorVel Corporation does not currently pay dividends.
What is CorVel Corporation’s EPS estimate?
CorVel Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CorVel Corporation have?
CorVel Corporation has 50,516,570 shares outstanding.
What happened to CorVel Corporation’s price movement after its last earnings report?
CorVel Corporation reported an EPS of $0.633 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.871%.
Which hedge fund is a major shareholder of CorVel Corporation?
Currently, no hedge funds are holding shares in CRVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CorVel Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
CRVL Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 20.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.16%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
15.45%
Trailing 12-Months
Company Description
CorVel Corporation
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
CRVL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong operational and financial positives: revenue and EPS growth (quarterly and fiscal), improved margins, robust new bookings (+56%) and pipeline expansion (RFPs +20%), cash generation, a debt-free balance sheet and aggressive share repurchases. Strategic wins for CERIS, expansion of prepaid solutions and continued AI/automation investments position the company for scalable growth. Offset risks include a higher effective tax rate, some one-time/timing-driven CERIS benefits that may not fully recur, only low single-digit growth in patient management, near-term staffing costs, and industry headwinds including rising claims severity and cybersecurity risks. Overall, the favorable results, expanding bookings and strong cash/return-of-capital program materially outweigh the noted challenges.View all CRVL earnings summariesTechnical Analysis
Brown & Brown
―
Crawford & Company A
―
Crawford & Company B
―
Baldwin Insurance Group
―
TWFG, Inc. Class A
―
Ownership Overview
39.37% Insiders
12.67% Mutual Funds
1.80% Other Institutional Investors
30.07% Public Companies and
Individual Investors